Rheumatology Article | Lupus Erythematosus, Systemic

14 Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation: Results of a randomized, dose-ranging study Full Text Arthritis …

Here is the original:
Rheumatology Article | Lupus Erythematosus, Systemic

No comments yet.

TOP